Safety and Tolerability of Intravenous Immunoglobulin in Chronic Inflammatory Demyelinating Polyneuropathy: Results of the ProCID Study-Reference-Cited by-同舟云学术

Safety and Tolerability of Intravenous Immunoglobulin in Chronic Inflammatory Demyelinating Polyneuropathy: Results of the ProCID Study

Published:2023-06-28 Issue:9 Volume:46 Page:835-845
ISSN:0114-5916
Container-title:Drug Safety
language:en
Short-container-title:Drug Saf

Author:

Cornblath David R.,van Doorn Pieter A.,Hartung Hans-Peter,Merkies Ingemar S. J.,Katzberg Hans D.,Hinterberger Doris,Clodi Elisabeth,Kastrev S.,Rizova V.,Milanov I.,Massie R.,Taleb R.,Bednar M.,Ridzon P.,Schmidt J.,Zschüntzsch J.,Csilla R.,Vécsei L.,Rejdak K.,Koszewicz M.,Budrewicz S.,Docu-Axelerad A.,Dulamea A.,Marian M.,Kadar A.,Zecheru-Lapusneanu L.,Mikhailov V.,Zakharov D.,Suponeva N.,Piradov M.,Smolko N.,Smolko D.,

Funder

Octapharma

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Toxicology

Link

https://link.springer.com/content/pdf/10.1007/s40264-023-01326-z.pdf

Reference35 articles.

1. Koike H, Katsuno M. Pathophysiology of chronic inflammatory demyelinating polyneuropathy: insights into classification and therapeutic strategy. Neurol Ther. 2020;9:213–27. https://doi.org/10.1007/s40120-020-00190-8.

2. Bunschoten C, Jacobs BC, van den Bergh PYK, Cornblath DR, van Doorn PA. Progress in diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy. Lancet Neurol. 2019;18:784–94. https://doi.org/10.1016/S1474-4422(19)30144-9.

3. van den Bergh PYK, van Doorn PA, Hadden RDM, Avau B, Vankrunkelsven P, Allen JA, et al. European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint Task Force-Second revision. Eur J Neurol. 2021;28:3556–83. https://doi.org/10.1111/ene.14959.

4. Hughes RAC, Donofrio P, Bril V, Dalakas MC, Deng C, Hanna K, et al. Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial. Lancet Neurol. 2008;7:136–44. https://doi.org/10.1016/S1474-4422(07)70329-0.

5. Merkies ISJ, van Schaik IN, Léger J-M, Bril V, van Geloven N, Hartung H-P, et al. Efficacy and safety of IVIG in CIDP: combined data of the PRIMA and PATH studies. J Peripher Nerv Syst. 2019;24:48–55. https://doi.org/10.1111/jns.12302.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rehabilitation of Peripheral Neuropathies: From Lexical Analysis of the Literature to Identification of Clinical Protocols;Journal of Clinical Medicine;2023-09-10

2. Restraint Stress-Induced Immunosuppression Is Associated with Concurrent Macrophage Pyroptosis Cell Death in Mice;International Journal of Molecular Sciences;2023-08-17

3. IV immunoglobulin well tolerated in chronic inflammatory demyelinating polyneuropathy;Reactions Weekly;2023-07-15